Silicon based materials for drug delivery devices and implants

Recent Patents on Nanotechnology

Volumn 1, Issue 3, 2007, Pages 186-192

  Bernik, Delia L ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Biomaterials; Drug delivery devices; Silicon based implants; Silicon devices

Indexed keywords

BIOACTIVE MATERIAL; DRUG DELIVERY DEVICES; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYBRID INORGANIC-ORGANIC; IMPLANT DEVICES; ORMOSILS; PATENT REVIEW; SILICA AEROGELS; SILICON DEVICES; SILICON-BASED; SILICON-BASED MATERIALS;

BIOLOGICAL MATERIALS; BIOMATERIALS; DRUG DELIVERY; HYBRID MATERIALS; IMPLANTS (SURGICAL); MEDICAL APPLICATIONS; SILICA; SILICA GEL; SILICON COMPOUNDS; SILICONES; TISSUE ENGINEERING;

PATENTS AND INVENTIONS;

BIOMATERIAL; SILICON; TISSUE SCAFFOLD;

ANIMAL; BONE PROSTHESIS; CHEMISTRY; DRUG DELIVERY SYSTEM; PROSTHESES AND ORTHOSES; REVIEW;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE SUBSTITUTES; DRUG DELIVERY SYSTEMS; PROSTHESES AND IMPLANTS; SILICON; TISSUE SCAFFOLDS;

EID: 66349120782     PISSN: 18722105     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221007782360402     Document Type: Article

References (80)

1. Jian FM, Naoki Y. Silicon uptake and accumulation in higher plants. Trends Plant Sci 2006; 11: 392-397.
2. Seaborn CD, Nielsen FH. Dietary silicon and arginine affect mineral element composition of rat femur and vertebra. Biol Trace Elem Res 2002; 89: 239-50.
3. Croce G, Viterbo D, Milanesio M, Amenitsch H. A mesoporous pattern created by nature in spicules from Thetya aurantium sponge. Biophys J 2007; 92: 288-292.
4. Kinrade SD, Gillson AME, Knight CTG. Silicon-29 NMR evidence of a transient hexavalent silicon complex in the diatom Navicula pelliculosa. J Chem Soc Dalton Trans 2002; 307-309.
5. Müller WE, Boreiko A, Wang X, et al. Silicateins, the major biosilica forming enzymes present in demosponges: Protein analysis and phylogenetic relationship. Gene 2007; 395: 62-71.
6. Lopez PJ, Gautier C, Livage J, Coradin T. Mimicking biogenic silica nanostructures formation. Curr Nanosci 2005; 1: 73-83.
7. Roy DM, Roy R. An experimental study of the formation and properties of synthetic serpentines and related layer silicate minerals. Am Mineral 1954; 39: 957-975.
8. Roy R. Aids in Hydrothermal Experimentation: II. Methods of making mixtures for both "Dry" and "Wet" phase equilibrium studies. J Am Ceram Soc 1956; 49: 145-146.
9. Iler RK. The Chemistry Of Silica. Wiley: New York 1955.
10. Badwan, A., Al-Remawi, M.: WO07025715 (2007).
11. Marrodan C.A.: US20067029706 (2006).
12. Chauveau, C., Zuccarelli. J.M., Nouri, N., Barbero, M.: US20067067149 (2006).
13. Barbé C, Bartlett J, Kong L., Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G. Silica particles: A novel drug-delivery system. Advanced Materials 2004; 16: 1959-1966.
14. Barbe, C., Bartlett, J.: US2005123611 (2005).
15. Cohen MH, Melnik K, Boiarsky AA, Ferrari M, Martin FJ. Microfabrication of silicon-based nanoporous particulates for medical applications. Biomed Microdevices 2003; 5: 253-259.
16. Ferrari, M., Dehlinger, P.J., Martin, F.J., Grove, C.F., Friend, D.R.: US20026355270 (2002).
17. Nashat AH, Moronne M, Ferrari M. Detection of functional groups and antibodies on microfabricated surfaces by confocal microscopy. Biotechnol Bioeng 1998; 60:137-146.
18. Foraker AB, Walczak RJ, Cohen MH, Boiarsky AA, Grove CF, Swaan PW. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm Res 2003; 20: 110-116.
19. Chen, I-Wei, Choi, H.: US20077189417 (2007).
20. Kistler SS. Coherent expanded aerogels and jellies. Nature 1931; 127: 741-745.
21. Kistler SS. Coherent Expanded-Aerogels. J Phys Chem 1932; 36: 52-64.
22. Smirnova I, Suttiruengwong S, Seiler M, Arlt W. Dissolution rate enhancement by adsorption of poorly soluble drugs on hydrophilic silica aerogels. Pharm Dev Technol 2005; 9: 443-452.
23. Suttiruengwong S, Rolker J, Smirnova I, et al. Hyperbranched polymers as drug carriers: Microencapsulation and release kinetics. Pharm Dev Technol 2006; 11:55-70.
24. Verness, D.D.: US2004215300 (2004).
25. Yoldas, B.E.: US5911658 (1999).
26. Yoldas; B.E.: US5746992 (1998).
27. Daitch, C.E., Brenizer, Jr. J.S., Hostick, B., Mason Jr., L.R., Norris, P.N., Luo, Ming, DeLucas, L.J.: US20026447991 (2002).
28. Ogorka, J., Kalb, O., Shah, R., Khanna, S.C.: US20036565883 (2003).
29. Ahola, M., Saeilynoja, E., Salonen, J., Penttinen, R., Yli-Urpo, A.: US20067112339 (2006).
30. Koskinen, M., Silynoja, E., Ahola, M., Salonen, J., Khri, V.M.: US20040120971 (2004).
31. Spange, S., Moszner, N., Burtscher, P., Rheinberger, V.: EP1281383 (2003).
32. Greenspan, DC. Bioactive glasses: the role of reactive surfaces and ionic release in effecting cellular response. In: "A Forecast of the Future for Biomaterials. " Prof. Larry L. Hench Retirement Symposium. Imperial College London 29th-30th September 2005. Department of Materials and the Tissue Engineering and Regenerative Medicine (TERM) Centre, Imperial College London
33. Hench LL. Sol-Gel Silica: Properties, Processing and Technology Transfer. Noyes Publications 1998, Westwood N.J., USA.
34. Hench LL, Wilson J. (Eds) Introduction to Bioceramics. 1993, World Scientific, London.
35. Vallet-Regí M, Salinas AJ, Arcos D. From the bioactive glasses to the star gels. J Mater Sci Mater Med 2006; 17: 1011-1017.
36. Leoni L., Desai TA. Micromachined biocapsules for cell-based sensing and delivery. Adv Drug Deliv Rev 2004; 56: 211-229.
37. Guarino V, Causa F, Ambrosio L. Bioactive scaffolds for bone and ligament tissue. Expert Rev Med Devices 2007; 4: 405-418.
38. Habraken WJ, Wolke JG, Jansen JA Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007; 59: 234-248.
39. Hench, L.L., West, J.K., LaTorre, G., Wilson. J., Toreki III, W., Batich, C.: US20016190684 (2001).
40. Litkowski, L.J., Hack, G.D., Greenspan, D.C.: US20016244871 (2001).
41. Ahola, M., Fagerholm, H., Kangasniemi, I., Kiesvaara, J., Kortesuo, P., Kurkela, K., Saarinen, N., Yli-Urpo, A.: US20046764690 (2004).
42. Gerber, T.: US20070059379 (2007).
43. Choi, H., Chen, I.-W.: WO05007802 (2005).
44. Wiegand, K.E., Hu, P.C.: US5183061 (1993).
45. Santamaría, R., Jesús, M., Arruebo, G.M., Coronas Ceresuela, J., Téllez Ariso, C., Navascués García, N.: WO06122998 (2006).
46. Briquet, F.J., Lord, G.: US20026406792 (2002).
47. Talton, J.D.: US20067063748 (2006).
48. Tan, W., Santra, S., Zhang, P., Tapec, R., Dobson, J.: US20056924116 (2005).
49. Darbandi M, Hoheisel W, Nann T. Silica coated, water dispersible and photoluminecscent Y(V, P)O4:Eu3+, Bi3+ nanophosphors. Nanotehcnology 2006; 17: 4168-4173.
50. Yang H, Santra S, Walter GA, Holloway PH. GdIII-functionalized fluorescent quantum dots as multimodal imaging probes. Adv Mater 2006; 18(21): 2890-2894.
51. Ying, J., Selvan, S., Yi, D., Lee, S.: WO06107331 (2006).
52. Dapprich, J.: US20036585939 (2003).
53. Chu, M., Xu, Y.: CN1616342 (2005).
54. Jordan, A., Waldoefner, N., Schols, R.: WO07019845 (2007).
55. McGhee, D., Britton, S.M., Lagwinska, E.: US20046767551 (2004).
56. Colas A, Curtis J. Silicon Biomaterials: History, Chemistry & Medical Applications of Silicones. In: Dow Corning Corporation. Biomaterials Science, 2nd Edition. Ratner, B.D., Hoffman, A.S., Schoen F.J., Lemans J.E., Eds. Elsevier, Academic Press, 2004; 80-86.
57. McClay, A.: CA2207622 (2006).
58. Chen, H.L., Shao, H.H., Chen, J.X., Chen, L.K.: US20050197651 (2005).
59. Greenberg, R.: US20077181287 (2007).
60. Lee, H., Daniel, K., Duc, H., Linh, H., Cima, M.J., Casillo-Ortiz, M., Froelich, S., Dimitrakov, J.: WO07021964A2 (2007).
61. Johnson, D.: US2007016289 (2007).
62. Siegel, R.: DE102004051195 (2006).
63. Cullen, C., Marten, L.H.: US20056966888 (2005).
64. Morris, G. M., Buralli, D.A., Federico, R.J.: US20077156516 (2007).
65. Gareth, T., Knowles, S.J., Trail, I.A.: GB2409979 (2005).
66. Wilkes GL, Orler B, Hyang HH. Solid-state 29Si NMR of TEOS-based multifunctional sol-gel materials. J Non-Cryst Solids 1989; 113: 73-87.
67. Hu Y, Mackenzie JD. Rubber-like Elasticity of Organically Modified Silicates. J Mater Sci 1992; 27:4415-4420.
68. Shimojima A, Kuroda K. Designed synthesis of nanostructured siloxaneorganic hybrids from amphiphilic silicon-based precursors. Chem Rec 2006; 6: 53-63.
69. Saliterman SS. Education, bioMEMS and the medical microdevice revolution. Expert Rev Med Devices 2005; 2: 515-519.
70. Tripathi VS, Kandimalla VB, Ju H. Preparation of ormosil and its applications in the immobilizing biomolecules. Sensors Actuators B: Chem 2006; 114: 1071-1082.
71. Giordano, R.A., Wu, B.M.: US20067052710 (2006).
72. Diaz, R.L., Ehlert, D.D., Campbell, D.R.: US20040220679 (2004).
73. Prasad, P.N., Bergey, E.J., Dutta, P., Bharali, D.J., Stachowiak M., Ohulchanskyy, T., Klejbor, I. Roy, I.: US20060088599 (2006).
74. Grayson ACR, Shawgo RS, Li Y. Cima YMJ. Electronic MEMS for triggered delivery. Adv Drug Deliv Rev 2004; 56:173-184.
75. Grayson ACR, Shawgo RS, Johnson AM, et al. BioMEMS review: MEMS technology for physiologically integrated devices Proceedings of the IEEE 2004; 92: 6-21.
76. Edell, D.J., Farrell, B.: WO02096482 (2002).
77. McCaskill, J., Maeke, T., Tangen, U., Wagler, P., Chemnitz, S., Juenger, M.: US20070111353 (2007).
78. Ouellet, L., Antaki, R.: US20077160752 (2007).
79. Rich, C.A., Zhang, Y., Najafi, N., Straayer, M.Z., Massoud-Ansari, S.: US20056926670 (2005).
80. Voskerician G, Shive MS, Shawgo RS, et al. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 2003; 24:1959-1967.